WELCOME TO THE DELVE BLOG.

Mobile Strategy for Clinical Trials

Mobile technologies are gaining greater acceptance and adoption in clinical trials, to engage patients, investigators, and study team

  • 90% of SMS are opened within 3 minutes

  • 85% of people prefer SMS over email or phone calls

  • 56% of the world population owns a smartphone

Every clinical trial needs a mobile strategy to get to patients, investigators, and study teams.

  • Collect digital endpoint

  • Notify Investigators of AE

  • Upcoming visit notification

  • Improve Medication adherence

  • Study team updates of any serious adverse events

50,000 health apps as of 2020

Virtually everyone has a smartphone these days, which theoretically means that investing in the development of a mobile app is a good idea. However, the problem is that mobile apps aren’t as effective as some of the studies and statistics have led us to believe.

  • 70% of smartphone users spend their time on just the three most frequently used apps.

  • 52% of apps lose half of their peak within three months of launch

SMS gains 98% better response rate over email or mobile app push notification

  • SMS is fast. You can send a message and the recipient will be notified within seconds
  • Apps are notoriously vulnerable to hackers
  • Can get to users wherever they are, using various messaging services

At Delve Health, we utilize various messaging solutions (i.e. SMS, WhatsApp, WeChat) for better global patient, investigator and study team reach.

  • Collect ePRO through SMS to gain up to 95% compliance
  • Deliver visit notifications to help reduce lost to follow-up
  • Notify investigators and study teams of possible adverse events

Delve Health’s Clinical StudyPal is a decentralized platform that can help engage sponsors, investigative sites, and patients to collect the most pertinent information. We help improve patient compliance in clinical trials, create better consent modules, and integrate with EDC/CTMS/eTMF/Wearables for better clinical trial conduct.

Reach out and talk to our experts on how to implement cost-effective ePRO/eDiary and notification solution for your clinical trial

 

SIMILAR ARTICLES

remote clinical trials | Delve Health

7 Ways to Increase Clinical Trial Patient Engagement with SMS & Messaging Apps

Most of us agree that a clinical trial’s success depends heavily on patient engagement. The importance of design patient-centric studies cannot be understated. Engaged
eConsent allows for video conferencing.

The Rise of eConsent Forms and its Impact on Patient Recruitment

Informed consent is one of the founding principles of research ethics. Its intent is that human participants can partake in medical research freely (i.e., voluntarily)
Delve Health delivers wearables directly to patients all over the world.

Delivering Devices and Safely Collecting Real-World Data (RWD)

Can we say something more around why we are focusing on collecting raw data from Wearables? Wearables are being implemented in more and more
banner | Delve Health

Are Wearables a Fade OR Are They Our Future?

Wearables in clinical research is a “hot topic” and all the “buzz.” While many people feel it will propel the clinical research enterprise into

What is eConsent

Defining eConsent in Clinical Trials The US Food and Drug Administration (FDA) has defined electronic informed consent (eConsent) in clinical trials as “the use of
Research In The United States | Delve Health

Opportunities In Transforming Clinical Research In The US

Clinical trials are essential for the development of new drugs and treatments. The goal of clinical trials is to find better ways to prevent,
Previous
Next